Shobiroh Nuur' Alimah, P. Puspita, L. Ambarsari, Riksa Nur Wahyuni
{"title":"INHIBISI ENZIM α-GLUKOSIDASE OLEH SENYAWA FLAVONOID DAUN KELOR (Moringa oleifera) IN SILICO DAN IN VITRO","authors":"Shobiroh Nuur' Alimah, P. Puspita, L. Ambarsari, Riksa Nur Wahyuni","doi":"10.29244/cb.10.2.3","DOIUrl":null,"url":null,"abstract":"Moringa leaves flavonoid have potential to inhibit α-glucosidase but they have low bioavailability, so they aremade in nanoparticles. It is also not known which specific flavonoid compounds from Moringa leaves have thepotential to inhibit α-glucosidase. This research aimed to determine the inhibition potential of α-glucosidase bythe moringa leaves flavonoid in silico through molecular docking and determine the inhibitory activity of α-glucosidase by moringa leaves flavonoid in extracts and nanoparticles in vitro. Moringa leaves flavonoid havepotential to be a competitive inhibiton of α-glucosidase with the highest to lowest inhibitory potential arecryptochlorogenic acid, quercetin-3-O-beta-D-glucopyranoside, quercetin-3-glucoside, kaempferol-3-O-a-ramnoside, kaempferol-3-O-glucoside, epicathechins, catechins, quercetin, kaempferol, glucomoringinisothiocyanate. Cryptochlorogenic acid has the best potential with ΔG and Ki values -8.5 kcal/mol and 0.5788μM. Inhibition α-glucosidase moringa leaves flavonoid in extract and nanoparticles respectively are classified asinactive (IC 50 = 5.84x10 3 ppm) and active (IC 50 = 1.59x10 1 ppm) in vitro, so nanoparticles can increase theinhibitory activity.","PeriodicalId":519054,"journal":{"name":"Current Biochemistry","volume":"30 12","pages":""},"PeriodicalIF":0.0000,"publicationDate":"2024-05-16","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"Current Biochemistry","FirstCategoryId":"1085","ListUrlMain":"https://doi.org/10.29244/cb.10.2.3","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"","JCRName":"","Score":null,"Total":0}
引用次数: 0
Abstract
Moringa leaves flavonoid have potential to inhibit α-glucosidase but they have low bioavailability, so they aremade in nanoparticles. It is also not known which specific flavonoid compounds from Moringa leaves have thepotential to inhibit α-glucosidase. This research aimed to determine the inhibition potential of α-glucosidase bythe moringa leaves flavonoid in silico through molecular docking and determine the inhibitory activity of α-glucosidase by moringa leaves flavonoid in extracts and nanoparticles in vitro. Moringa leaves flavonoid havepotential to be a competitive inhibiton of α-glucosidase with the highest to lowest inhibitory potential arecryptochlorogenic acid, quercetin-3-O-beta-D-glucopyranoside, quercetin-3-glucoside, kaempferol-3-O-a-ramnoside, kaempferol-3-O-glucoside, epicathechins, catechins, quercetin, kaempferol, glucomoringinisothiocyanate. Cryptochlorogenic acid has the best potential with ΔG and Ki values -8.5 kcal/mol and 0.5788μM. Inhibition α-glucosidase moringa leaves flavonoid in extract and nanoparticles respectively are classified asinactive (IC 50 = 5.84x10 3 ppm) and active (IC 50 = 1.59x10 1 ppm) in vitro, so nanoparticles can increase theinhibitory activity.